Shashi Bellam to Respiration, Artificial
This is a "connection" page, showing publications Shashi Bellam has written about Respiration, Artificial.
Connection Strength
0.075
-
Randomized Phase 3 Trial of Ruxolitinib for COVID-19-Associated Acute Respiratory Distress Syndrome. Crit Care Med. 2022 12 01; 50(12):1701-1713.
Score: 0.038
-
Assessment of Awake Prone Positioning in Hospitalized Adults With COVID-19: A Nonrandomized Controlled Trial. JAMA Intern Med. 2022 06 01; 182(6):612-621.
Score: 0.037